Evonik completes sale of its Lülsdorf chemical site near Cologne, Germany, to International Chemical Investors Group; company has also transferred the associated cyanuric chloride business in Wesseling to ICIG

Sample article from our Chemicals Industry

July 3, 2023 (press release) –

Michael Richter
Communications  
Stefanie Mielke
Site Communication Wesseling 
  • Sale completed June 30
  • Concentration on specialty chemicals continues
  • Investor acquires entire site and associated cyanuric chloride business in Wesseling, Germany

Essen, Germany. The chemical site in Lülsdorf near Cologne now officially belongs to the International Chemical Investors Group (ICIG). The sale of the site, which was announced at the beginning of April, was completed June 30 after the necessary approvals were obtained from the antitrust authorities, among others. Along with the Lülsdorf site, the associated cyanuric chloride business in Wesseling has also been transferred to ICIG.

The businesses were previously part of Evonik's Performance Materials Division. With their sale, Evonik has implemented the first step in divesting all three parts of the division. ICIG is taking over the more than 600 employees and all production facilities. Extensive protective rights have been agreed for employees.

Evonik had begun preparing for the sale in the fall of 2021. The preferred solution from the outset was to sell the site whole to a new owner. With ICIG, Evonik chose an experienced chemical investor with extensive expertise in site development. ICIG is already active with subsidiaries in the chlorine chemicals and specialty chemicals industries and plans to further expand the Lülsdorf site and the acquired businesses.

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €18.5 billion and an operating profit (adjusted EBITDA) of €2.49 billion in 2022. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 34,000 employees work together for a common purpose: We want to improve life today and tomorrow.

The International Chemical Investors Group is a privately owned industrial group privately owned with total sales of approximately €4 billion. ICIG focuses on four main platforms: Fine Chemicals under the WeylChem brand, Chlorovinyls under the Vynova brand, Compounds under the Benvic brand, and Enterprises with specialized companies in sodium metal, industrial drying services, fermentation products, viscose filaments, activated carbon and wood preservation chemicals. Today, the ICIG companies employ approximately 5,100 people and operate more than 35 manufacturing facilities in Europe and the United States. Additional information can be found at www.ic-investors.com.

In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

More from our Chemicals Industry Coverage
See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order chemicals industry coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.